Increased Cardiac Troponin T Levels Are Related to Inflammatory Markers and Various Indices of Renal Function in Chronic Renal Disease Patients

REFERENCES

• Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:16–23.
   PubMed Web of Science ®Google Scholar
• Manjunath G, Tighiouart H, Coresh J, Macleod B. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63:1121–1129.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169.
   PubMed Web of Science ®Google Scholar
• Urso S, Garozzo M, Milone F, Battaglia G. Cardiovascular risk markers in hemodialysis patients. Int J Artif Organs. 2004;27:1083–1090.
   PubMedGoogle Scholar
• Abbas NA, John RI, Webb MC, Kempson ME. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem. 2005;51:2059–2066.
   PubMed Web of Science ®Google Scholar
• Ooi DS, House AA. Cardiac troponin T in hemodialyzed patients. Clin Chem. 1995;44:1410–1416.
   Google Scholar
• Dierkes J, Domrose U, Westphal S, Ambrosch A. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation. 2000;102:1964–1969.
   PubMed Web of Science ®Google Scholar
• Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941–2945.
   PubMed Web of Science ®Google Scholar
• Ishii J, Nomura M, Okuma T, Minagawa T. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta. 2001;312:69–79.
   PubMedGoogle Scholar
• Diris JH, Hackeng CM, Kooman JP, Pinto YM. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004;109:23–25.
   PubMed Web of Science ®Google Scholar
• Sharma R, Gaze DC, Pellerin D. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart. 2006;92:804–809.
   PubMed Web of Science ®Google Scholar
• Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: Incidence and clinical significance. Chest. 2004;125:1877–1884.
   PubMed Web of Science ®Google Scholar
• Lamb EJ, Wbb MC, Abbas NA. The significance of serum troponin T in patients with kidney disease: A review of the literature. Ann Clin Biochem. 2004;41:1–9.
   Google Scholar
• National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: Evaluation classification and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   Google Scholar
• Platt JF, Ellis JH, Rubin JM. Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: Correlation of resistive index with biopsy findings. AJR Am J Roentgenol. 1990;154:1223–1227.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–618.
   PubMed Web of Science ®Google Scholar
• Koren MJ, Devereux RB, Casale PN, Savage DD. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–352.
   PubMed Web of Science ®Google Scholar
• Collinson PO, Hadcocks L, Foo Y, Rosalki SB. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem. 1998;35:380–386.
   PubMed Web of Science ®Google Scholar
• Wood GN, Keevil B, Gupta J, Foley R. Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: A 2 year prospective study. Nephrol Dial Transplant. 2003;18:1610–1615.
   PubMedGoogle Scholar
• Roppolo LP, Fitzgerald R, Dillow J, Ziegler T. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a veteran’s hospital: A pilot study. J Am Coll Cardiol. 1999;34:448–454.
   PubMed Web of Science ®Google Scholar
• Goicoechea M, Garca de Vinuesa S, Gomez-Campdera F, Gutierrez MJ. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: Predictive value for cardiovascular risk. Am J Kidney Dis. 2004;43:846–853.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Benedetto FA, Mallamaci F. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens. 2000;18:1207–1213.
   PubMedGoogle Scholar
• Stenvinkel P. Inflammation in end-stage renal disease: The hidden enemy. Nephrology (Carlton). 2006;11:36–41.
   PubMed Web of Science ®Google Scholar
• Lowbeer C, Stenvinkel P, Pecoits-Filho R. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med. 2003;253:153–160.
   PubMedGoogle Scholar
• Baldus S, Koster R, Chumley P, Heitzer T. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med. 2005;39:1184–1190.
   PubMed Web of Science ®Google Scholar
• Fredericks S, Chang R, Gregson H, Bewick M. Circulating cardiac troponin-T in patients before and after renal transplantation. Clin Chim Acta. 2001;310:199–203.
   Google Scholar
• Freda BJ, Tang WH, Van Lente F, Peacock WF. Cardiac troponins in renal insufficiency: Review and clinical implications. J Am Coll Cardiol. 2002;40:2065–2071.
   PubMed Web of Science ®Google Scholar
• Vickery S, Price CP, John RI, Abbas NA. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: Relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis. 2005;46:610–620.
   PubMed Web of Science ®Google Scholar
• Madsen LH, Ladefoged S, Corell P, Schou M. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int. 2007;71:548–554.
   PubMed Web of Science ®Google Scholar
• Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol. 1998;9:1018–4022.
   PubMedGoogle Scholar
• Amann K, Ritz E. Cardiac disease in chronic uremia: Pathophysiology. Adv Ren Replace Ther. 1997;4:212–224.
   PubMedGoogle Scholar
• Kaye D, Pimental D, Prasad S, Maki T. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest. 1996;97:281–291.
   PubMed Web of Science ®Google Scholar
• deFilippi CR, Thorn EM, Aggarwal M, Joy A. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol. 2007;100:885–889.
   Google Scholar